HEATHER HITT: Open Payments
NPI 1417603069 · SAVANNAH, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$333 in 17 payments from 11 companies in 2025. Trend: 2023 $1,702 · 2024 $1,170 · 2025 $333
Food & beverage: $333
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 4 | $92 |
| Calliditas Therapeutics US Inc. | 3 | $60 |
| GlaxoSmithKline, LLC. | 2 | $31 |
| Ardelyx, Inc. | 1 | $26 |
| Travere Therapeutics, Inc. | 1 | $24 |
| Alnylam Pharmaceuticals Inc. | 1 | $24 |
| Apellis Pharmaceuticals, Inc. | 1 | $16 |
| Vifor Pharma, Inc. | 1 | $15 |
| Aurinia Pharma U.S., Inc. | 1 | $15 |
| Mallinckrodt Hospital Products Inc. | 1 | $15 |
Products named: Fabhalta, TARPEYO, IBSRELA, GIVLAARI, SHINGRIX, Empaveli, Veltassa, LUPKYNIS.
Industry payments across GA — which companies pay providers there.
